ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
G

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine + Cisplatin in Advanced Cholangiocarcinoma With a FGFR2 Gene Fusion/Rearrangement: PROOF 301 Trial

By ASCO 2022 Conference Coverage FEATURING Ghassan Abou-Alfa
By ASCO 2022 Conference Coverage FEATURING Ghassan Abou-Alfa
104 views
June 7, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das
GI
10:11

ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib i…

ASCO 2022 Conference Coverage

M. Rimini

278 views
07:56

ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Ag…

ASCO 2022 Conference Coverage

B. Johnson

97 views
03:33

ASCO 2022 Patient-Reported Outcomes From the Phase 3 HIMALAYA Study …

ASCO 2022 Conference Coverage

P. Galle

73 views
02:15

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA An…

ASCO 2022 Conference Coverage

J. Tie

18 views
07:51

Updates on the PARADIGM Trial: PAN + mFOLFOX6 vs. BEV + mFOLFOX6 as …

ASCO 2022 Conference Coverage

T. Yoshino

161 views
01:21

Lecture Summary - ASCO 2022 on Phase 3 CAIRO5 Study: FOLFOXIRI + Bev…

ASCO 2022 Conference Coverage

C. Punt

20 views
07:57

ASCO 2022 on Phase I/II Trial of Encorafenib, Cetuximab, & Nivolumab…

ASCO 2022 Conference Coverage

V. Morris

342 views
59

Lecture Summary - ASCO 2022 on Phase I/II Trial of Encorafenib, Cetu…

ASCO 2022 Conference Coverage

V. Morris

14 views
07:35

ASCO 2022 on an Open-Label, Multicenter, Randomized Phase II Study o…

ASCO 2022 Conference Coverage

A. Ruth He, F. Banovac

238 views
40

Lecture Summary - ASCO 2022 on an Open-Label, Multicenter, Randomize…

ASCO 2022 Conference Coverage

A. Ruth He, F. Banovac

15 views
58

Lecture Summary - ASCO 2022 on EA2183: A Phase III Study of Consolid…

ASCO 2022 Conference Coverage

N. Uboha

229 views
06:44

ASCO 2022 on EA2183: A Phase III Study of Consolidative RT in Patien…

ASCO 2022 Conference Coverage

N. Uboha

511 views
05:40

ASCO 2022 Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant…

ASCO 2022 Conference Coverage

D. Takahari

130 views
11:07

ASCO 2022 The Differential Response to Immune Checkpoint Inhibitors …

ASCO 2022 Conference Coverage

M. Khushman

88 views
06:33

ASCO 2022 Testing of a Machine Learning Model for Ability to Predict…

ASCO 2022 Conference Coverage

M. Sun

11 views
05:53

ASCO 2022 on a Regional Subgroup Analysis of the Phase 3 TOPAZ-1 Stu…

ASCO 2022 Conference Coverage

A. Vogel

153 views
04:54

ASCO 2022 IMMUTACE - A Biomarker-Orientated Phase II, Single-Arm, Op…

ASCO 2022 Conference Coverage

A. Vogel

96 views
05:30

ASCO 2022 on SWOG S2012: Randomized Phase II/III Trial of 1L Platinu…

ASCO 2022 Conference Coverage

D. Zhen

9 views
05:12

ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Saf…

ASCO 2022 Conference Coverage

A. Vogel

341 views
10:29

ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for …

ASCO 2022 Conference Coverage

P. Kasi

219 views
58

Lecture Summary - ASCO 2022 Targeting HER2 Mutation-Positive Advance…

ASCO 2022 Conference Coverage

J. Harding

16 views
54

Lecture Summary - ASCO 2022 on ctDNA Profile in Pancreatic Ductal Ad…

ASCO 2022 Conference Coverage

F. Esposito

17 views
09:42

ASCO 2022 Targeting HER2 Mutation-Positive Advanced Biliary Tract Ca…

ASCO 2022 Conference Coverage

J. Harding

91 views
05:39

ASCO 2022 on ctDNA Profile in Pancreatic Ductal Adenocarcinoma and P…

ASCO 2022 Conference Coverage

F. Esposito

885 views
04:22

ASCO 2022 on the Multicenter Phase Ib US Trial of Salvage CT041 CLDN…

ASCO 2022 Conference Coverage

G. Botta

140 views
01:26

Lecture Summary - ASCO 2022 on the Multicenter Phase Ib US Trial of …

ASCO 2022 Conference Coverage

G. Botta

26 views
01:13

Lecture Summary - ASCO 2022 on Investigating a Switch Maintenance Co…

ASCO 2022 Conference Coverage

S. Stintzing

24 views
55

Lecture Summary - ASCO 2022 on Perioperative Ramucirumab + FLOT vs. …

ASCO 2022 Conference Coverage

T. Oliver Götze

17 views
07:37

ASCO 2022 on Investigating a Switch Maintenance Concept With 5-FU + …

ASCO 2022 Conference Coverage

S. Stintzing

204 views
08:49

ASCO 2022 on the Phase 2/3 Study of an Individualized Neoantigen Vac…

ASCO 2022 Conference Coverage

J. Hecht

155 views
34

Lecture Summary - ASCO 2022 on the Phase 2/3 Study of an Individuali…

ASCO 2022 Conference Coverage

J. Hecht

53 views
06:16

ASCO 2022 on NSABP FC-10: A Phase Ib Study of Pembro + Pemetrexed & …

ASCO 2022 Conference Coverage

J. Krauss

73 views
34

Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as …

ASCO 2022 Conference Coverage

C. Cremolini

44 views
11:34

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment …

ASCO 2022 Conference Coverage

C. Cremolini

191 views
09:20

ASCO 2022 on the Comparative Efficacy of Novel Combination IO Strate…

ASCO 2022 Conference Coverage

C. Fulgenzi

219 views
40

Lecture Summary - ASCO 2022 on Multicenter Phase II Study of Abemaci…

ASCO 2022 Conference Coverage

R. Kelly

18 views
05:15

ASCO 2022 on Multicenter Phase II Study of Abemaciclib & Ramucirumab…

ASCO 2022 Conference Coverage

R. Kelly

234 views
31

Lecture Summary - ASCO 2022 NEOPRISM CRC: Neoadjuvant Pembrolizumab …

ASCO 2022 Conference Coverage

K. Shiu

36 views
15:40

ASCO 2022 NEOPRISM CRC: Neoadjuvant Pembrolizumab Stratified to Tumo…

ASCO 2022 Conference Coverage

K. Shiu

1.1K views
01:02

Lecture Summary - ASCO 2022 on Pembrolizumab + mFOLFOX7/FOLFIRI for …

ASCO 2022 Conference Coverage

R. Kim

358 views
08:41

ASCO 2022 on KEYNOTE-651: Pembrolizumab + mFOLFOX7/FOLFIRI for mCRC:…

ASCO 2022 Conference Coverage

R. Kim

2.3K views
43

Lecture Summary - ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (C…

ASCO 2022 Conference Coverage

M. Overman

19 views
04:11

ASCO 2022 on CRC Metastatic dMMR Immuno-Therapy (COMMIT) Phase 3 Stu…

ASCO 2022 Conference Coverage

M. Overman

1.1K views
39

Lecture Summary - ASCO 2022 Immunotherapy With Nivolumab After Progr…

ASCO 2022 Conference Coverage

A. Rauthan

117 views
09:02

ASCO 2022 Immunotherapy With Nivolumab After Progression on Lenvatin…

ASCO 2022 Conference Coverage

A. Rauthan

235 views
23

Lecture Summary - ASCO 2022 Updates on Infigratinib vs. Gemcitabine …

ASCO 2022 Conference Coverage

G. Abou-Alfa

104 views
06:42

ASCO 2022 on PROOF 301 Trial: Updates on Infigratinib vs. Gemcitabin…

ASCO 2022 Conference Coverage

G. Abou-Alfa

1.1K views